Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Browse By Topic
Economics & Value
Economics & Value
Articles about real-world healthcare utilization and costs on Value-Based Cancer Care.
Filter by Topic
Accountable Care Organization
Community Oncology
Comparative Effectiveness
Comparative Effectiveness Research
Economics of Cancer Care
Health Economics
Oncology Benefit Edition
Payer-Provider
Pricing
Reimbursement
Value-Based Care
Substantial Costs Associated with Systemic Therapy After Ipilimumab in Patients with Advanced Melanoma
By
Laura Morgan
Economics & Value
,
Economics of Cancer Care
May 2015, Vol 6, No 4
San Diego, CA—The healthcare costs of patients with advanced melanoma after ipilimumab (Yervoy) therapy are significant, according to recent study findings presented at the 2015 Academy of Managed Care Pharmacy annual meeting.
Read Article
Medicare’s Sustainable Growth Rate Repeal Met with Relief
By
Laura Morgan
Economics & Value
,
Economics of Cancer Care
May 2015, Vol 6, No 4
The April 14, 2015, repeal of the sustainable growth rate (SGR) formula for physician payments under Medicare is being welcomed by the healthcare community, including the American Society of Clinical Oncology (ASCO). The 392 to 37 vote to pass H.R. 2, called the Medicare Access and Children’s Health Insurance Program Reauthorization Act of 2015, came just in time to avoid the 21% cut in Medicare fees that would have come into effect after the most recent SGR patch expired on March 31, 2015.
Read Article
US Oncologists Favor Establishment of NICE-Like Body to Determine Medicare Cancer Drugs Reimbursement
By
Rosemary Frei, MSc
Economics & Value
,
Economics of Cancer Care
May 2015, Vol 6, No 4
Read Article
Value Propositions - May 2015
Economics & Value
,
Value Propositions
,
Value Peer-spectives
May 2015, Vol 6, No 4
Read Article
Value of Cancer Care for Most Tumors Lower in United States than in Western Europe
By
Rosemary Frei, MSc
Economics & Value
,
Economics of Cancer Care
May 2015, Vol 6, No 4
A reevaluation of the value of cancer care between 1982 and 2010 in the United States versus Western Europe (Soneji S, Yang JW. Health Aff [Millwood]. 2015;34:390-397) paints an entirely different picture from a similar analysis published in 2012 (Philipson T, et al. Health Aff [Millwood]. 2012;31:667-675). The earlier study found significant improvements in breast and prostate cancer survival in the United States relative to Western Europe, concluding that the high costs in the United States were worth it.
Read Article
Choice of Hospital for Readmissions Influences Mortality Risk in Men with Urologic Cancer
By
Chase Doyle
Economics & Value
,
Economics of Cancer Care
April 2015, Vol 6, No 3
Orlando, FL—Patients with urologic cancer who are readmitted after a surgery to a second hospital and not to their original hospital are more likely to have complications than patients readmitted to their original surgical hospital, according to findings presented at the 2015 Genitourinary Cancers Symposium.
Read Article
Millions in Savings by Using Prolaris Test in All Men with Localized Prostate Cancer
By
Alice Goodman
Economics & Value
,
Economics of Cancer Care
April 2015, Vol 6, No 3
Orlando, FL—Significant cost-savings in treating patients with prostate cancer could be achieved in the US healthcare system with the use of the cell-cycle progression (CCP) gene-expression assay called Prolaris (from Myriad Genetics Laboratories), according to a poster from E. David Crawford, MD, Professor of Surgery and Radiation Oncology, University of Colorado, Aurora, and colleagues, presented at the 2015 Genitourinary Cancers Symposium.
Read Article
Insurance Status Impacts Ability to Travel for Care
By
Chase Doyle
Economics & Value
,
Economics of Cancer Care
April 2015, Vol 6, No 3
Orlando, FL—Patients undergoing complex oncologic procedures, such as radical cystectomy, radical prostatectomy, or percutaneous nephrolithotomy, are more likely to travel outside of their regions if they have private insurance, potentially reflecting better access to care based on income, according to findings presented at the 2015 Genitourinary Cancers Symposium.
Read Article
Sunitinib Associated with Higher Costs Compared with Pazopanib in Patients with Renal-Cell Carcinoma
By
Chase Doyle
Economics & Value
,
Economics of Cancer Care
April 2015, Vol 6, No 3
Hollywood, FL—Sunitinib and pazopanib have long battled for supremacy in treating advanced renal-cell carcinoma (RCC). According to findings presented at the 2015 National Comprehensive Cancer Network (NCCN) conference, the newer drug, pazopanib, may have some advantage in terms of total cost of care, but survival outcomes were exactly the same.
Read Article
IOM Strategies for Lowering Out-of-Pocket Costs of Cancer Drugs
By
Rosemary Frei, MSc
Economics & Value
,
Economics of Cancer Care
April 2015, Vol 6, No 3
At a June 2014 Institute of Medicine (IOM) workshop on patient access to oncology drugs, several cancer experts discussed various strategies on how to lower out-of-pocket (OOP) costs of oncology drugs for patients with cancer.
Read Article
Page 8 of 18
3
4
5
6
7
8
9
10
11
12
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
Wayne Kuznar
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma